iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Acquired by EFG Asset Management North America Corp.

EFG Asset Management North America Corp. boosted its position in iRhythm Technologies, Inc. (NASDAQ:IRTC) by 113.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,430 shares of the company’s stock after buying an additional 15,118 shares during the quarter. EFG Asset Management North America Corp. owned 0.09% of iRhythm Technologies worth $2,565,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of iRhythm Technologies by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 3,136,370 shares of the company’s stock worth $282,806,000 after acquiring an additional 18,442 shares during the last quarter. State Street Corp grew its stake in iRhythm Technologies by 1.3% during the 3rd quarter. State Street Corp now owns 908,843 shares of the company’s stock valued at $67,473,000 after purchasing an additional 11,992 shares in the last quarter. Braidwell LP increased its holdings in iRhythm Technologies by 48.7% during the 3rd quarter. Braidwell LP now owns 782,557 shares of the company’s stock worth $58,097,000 after purchasing an additional 256,200 shares during the last quarter. Eventide Asset Management LLC raised its position in shares of iRhythm Technologies by 170.8% in the 3rd quarter. Eventide Asset Management LLC now owns 736,721 shares of the company’s stock valued at $54,694,000 after purchasing an additional 464,629 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of iRhythm Technologies by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 733,308 shares of the company’s stock valued at $54,451,000 after buying an additional 5,423 shares during the last quarter.

Wall Street Analyst Weigh In

IRTC has been the subject of a number of research analyst reports. Truist Financial lifted their price target on shares of iRhythm Technologies from $111.00 to $145.00 and gave the stock a “buy” rating in a research note on Friday, February 21st. The Goldman Sachs Group boosted their target price on shares of iRhythm Technologies from $91.00 to $124.00 and gave the stock a “neutral” rating in a research report on Monday, February 24th. Wells Fargo & Company increased their price target on shares of iRhythm Technologies from $86.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Friday, February 21st. Canaccord Genuity Group lifted their price target on iRhythm Technologies from $125.00 to $152.00 and gave the stock a “buy” rating in a research note on Monday, December 9th. Finally, StockNews.com upgraded iRhythm Technologies from a “sell” rating to a “hold” rating in a research note on Monday, February 24th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, iRhythm Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $119.73.

iRhythm Technologies Stock Up 0.7 %

NASDAQ:IRTC opened at $106.60 on Wednesday. The company has a current ratio of 6.27, a quick ratio of 6.12 and a debt-to-equity ratio of 9.00. The stock has a 50 day moving average of $108.14 and a 200-day moving average of $89.47. The firm has a market capitalization of $3.35 billion, a PE ratio of -29.29 and a beta of 1.36. iRhythm Technologies, Inc. has a 52 week low of $55.92 and a 52 week high of $128.52.

iRhythm Technologies (NASDAQ:IRTC) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.01 EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.30. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. The firm had revenue of $164.33 million during the quarter, compared to the consensus estimate of $158.30 million. Analysts predict that iRhythm Technologies, Inc. will post -1.98 EPS for the current year.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.